What Are the Effects of Treatments for Sialorrhea in People With Motor Neuron Disease/Amyotrophic Lateral Sclerosis?: A Cochrane Review Summary With Commentary
- PMID: 37126792
- DOI: 10.1097/PHM.0000000000002272
What Are the Effects of Treatments for Sialorrhea in People With Motor Neuron Disease/Amyotrophic Lateral Sclerosis?: A Cochrane Review Summary With Commentary
Conflict of interest statement
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.
Comment on
-
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article.
References
-
- James E, Ellis C, Brassington R, et al.: Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Sys Rev 2022;5:CD006981
-
- Van Es MA, Hardiman O, Chio A, et al.: Amyotrophic lateral sclerosis. Lancet 2017;390:2084–98
-
- Simonds AK: Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis? Thorax 2017;72:199–201
-
- Morgante F, Bavikatte G, Anwar F, et al.: The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®). Ther Adv Neurol Disord 2019;12:1756286419888601
-
- Garuti G, Rao F, Ribuffo V, et al.: Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis 2019;9:19–26
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical